As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: November 2, 2012
by HealthDay News:
If you live long enough, a potentially harmful gene linked to Alzheimer’s disease may lose its punch, according to a new study.
The ApoE4 gene is linked to the risk of developing Alzheimer’s, heart disease and diabetes. This study found that the gene becomes less important once people reach their 90s.
Mayo Clinic researchers looked at 121 people, ages 90 to 99, in Olmsted County, Minn., who were living on their own in or long-term care facilities. The participants completed an interview, had a physical exam and filled out a quality-of-life questionnaire. Blood samples were taken for genetic analysis.
People with the ApoE4 gene were no worse off than those without the gene, the investigators found.
“We found if people had good physical, intellectual, and emotional well-being, more social connectedness, and if they perceived themselves to have better coping skills, they felt they had better quality of life,” study co-author and psychiatrist Dr. Maria Lapid said in a Mayo news release.
“The study shows that the ApoE4 genotype doesn’t determine what your quality of life will be, and that, regardless of your gender, environmental factors play a significant role in your physical, emotional, spiritual, and social well-being,” she explained. “You can have good quality of life regardless of this gene.”
The findings were published in the October Journal of the American Medical Directors Association.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.